ZEPHIR , Helene

Last name: ZEPHIR

First name: Helene

October 26, 2022 (v1)

Publication

Metadata-only

Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study

Cohen, Mikael Thomel-Rocchi, Océane Siva, Aksel

Introduction: Nowadays, mandatory vaccination in patients with multiple sclerosis (MS) is widely recommended. Regarding COVID19, the absence of specific warnings led to the proposal of vaccination in patients with inflammatory diseases of the central nervous system. However global vaccination hesitancy remains and potential effect of COVID19...

Uploaded on: October 23, 2024
June 23, 2023 (v1)

Journal article

Metadata-only

Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis

Januel, Edouard Hajage, David Labauge, Pierre

Importance In patients with multiple sclerosis (MS), factors associated with severe COVID-19 include anti-CD20 therapies and neurologic disability, but it is still unclear whether these 2 variables are independently associated with severe COVID-19 or whether the association depends on MS clinical course. Objective To assess the association...

Uploaded on: September 25, 2024
February 2024 (v1)

Journal article

Metadata-only

Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis

Benallegue, Nail Rollot, Fabien Wiertlewski, Sandrine

Importance: Moderately effective therapies (METs) have been the main treatment in pediatric-onset multiple sclerosis (POMS) for years. Despite the expanding use of highly effective therapies (HETs), treatment strategies for POMS still lack consensus.Objective: To assess the real-world association of HET as an index treatment compared with MET...

Uploaded on: February 16, 2024

ZEPHIR , Helene

Recent uploads